Dabur India Limited: History, Latest Updates, Milestones, Subsidiaries & Share Price
Introduction
Dabur India Limited ,established in 1884 by Bruman Family members is a renowned FMCG company with a strong revenue of Rs.12400 crore and a market capitalization of Rs.1 lakh crore. Dabur , a 139 years old company in Ayurvedic is the largest Ayurvedic and Natural healthcare company globally. Currently, Dabur’s products are sold in 7.7 million retail shops in 120 + countries, with 250 + Ayurvedic and herbal products. Dabur’s key segments include healthcare, personal care and food & beverages.
Dabur’s success stems from its ability to integrate ancient Ayurvedic wisdom with modern scientific advancements, creating products that meet the evolving needs of consumers worldwide. Having transitioned from a family-run business to a professionally managed organization, Dabur continues to set new benchmarks in corporate governance and innovation, solidifying its position as a global leader in Ayurveda and natural healthcare.
Dabur India Limited Moves In 2025
January–March 2025
In the first quarter of 2025, Dabur India focused on developing its portfolio of products and building its rural market presence. Investor interactions reflected Dabur's focus on strengthening premium product offerings and stepping up digital engagement for driving growth. These initiatives were warily observed by market players monitoring Dabur share price action.
April–June 2025
Dabur announced its Q4 FY 2024-25 financial results in early May, posting a net profit of Rs 320 crore and revenue of Rs 2,830 crore. The food business segment reflected robust momentum with a growth rate of more than 14% and was a positive contributor to overall business performance. During this time, the company reiterated emphasis on cost efficiencies and sustainable sourcing. These trends contributed to sustained investor confidence and shaped Dabur share price movements.
July 2025
By July end, Dabur announced its Q1 FY 2025-26 financials, showing a 3% year-on-year increase in consolidated net profit, at Rs 514 crore, and 2% revenue increase to Rs 3,405 crore. The ex-seasonal portfolio of the company increased by 7%, showing strength across its core categories in an otherwise difficult environment. The quarterly report with a good tone fueled upside in Dabur share price in this month.
August 2025
Dabur conducted its 50th Annual General Meeting in early August, during which it launched an aggressive growth plan with a focus on deeper rural market penetration, new premium product introductions, and strong sustainability initiatives, including the sourcing of 61% of energy from renewable sources. The firm also increased its distribution network to 8.4 million retail points, supporting its long-term sales strategy. These disclosures created optimism among the investors and stabilized Dabur share price in the face of mild market fluctuations.
September 2025
During September, Dabur also showed consistent performance. The Dabur share price, as of the end of September, was in the vicinity of Rs 515, showing a slight decrease from previous levels but remaining on a safe level driven by the firm's steady operating performance. Market experts observed a small decline of around 3.86% week-on-week, putting it down to industry-wide corrections as opposed to company-specific concerns. The one-year target price was given at around Rs 555, reflecting a positively guarded expectation by market analysts.
Evolution Of Dabur India Limited: From Past to Present
|
Year |
Evolution |
|
1884 |
Dr. S.K. Burman established Dabur at Kolkata, India |
|
1896 |
Set up a Dabur mass production manufacturing plant |
|
Early 1900s |
Dabur entered into Ayurvedic medicines |
|
1919 |
Dabur established Research laboratories for the process of scientific data and quality checks. |
|
1920 |
Dabur established two more manufacturing units at Narendrapur and Daburgram. Dabur expanded to Bihar and North East. |
|
1936 |
Dabur established as company ‘ Dabur India (Dr.S.K. Burman) Private Limited’ |
|
1972 |
Dabur shifted its business to Delhi with a new manufacturing unit at Faridabad. |
|
1979 |
Dabur established Dabur R&D centre. Dabur established commercial production of Ayurvedic medicine at Sahibabad Factory. |
|
1986 |
Dabur converted into Dabur India Limited |
|
1992 |
Dabur in joint venture with Agrolimen, Spain for manufacture of confectioneries. |
|
1993 |
Dabur expands its business to cancer care with its new plant at Baddi, Himachal Pradesh |
|
1994 |
Dabur raised funds through IPO where the Dabur share price was oversubscribed by 21 times. |
|
1995 |
Dabur in joint venture with Bangrain , France for dairy products. |
|
1996 |
Dabur created three separate divisions such as Health, Family and Ayurvedic |
|
1997 |
Dabur launched Project STARS and processed food division |
|
1998 |
Dabur included a non-family member as CEO first time |
|
2000 |
Dabur turnover crosses Rs. 1000 crores. |
|
2003 |
Dabur demerged pharmaceuticals and FMCG business |
|
2005 |
Dabur acquired an entity named Balsara which deals in oral care business . Dabur announced Bonus issue of Dabur share price to bonus at ratio of 1:1 |
|
2006 |
Dabur’s market capitalization crosses $2 billion. Dabur adopted to Unted States GAAP . Dabur raised funds from international market through bonds, FCCBs, GDR, ADR , QIPs etc.. for value of $200 million |
|
2007 |
Dabur updated the look of ‘REAL’ at REAL’s 10 years completion. Dabur enters into retail chain through its subsidiary H&B Stores Limited. Dabur invested Rs. 140 crores in retail through Health & Beauty format . Dabur merged its own subsidiary “Dabur Foods Limited’ |
|
2008 |
Dabur acquired Fem Care Pharma |
|
2009 |
Dabur Red Paste crosses billion-rupee turnover. |
|
2010 |
Dabur acquired Hobi Kozmetik Group, Turkey for $69 million and Namaste Laboratories LLC , United States for $100 million |
|
2011 |
Dabur launched Oxylife Professional Facial Kit. Dabur acquired OTC product ‘ 30- Plus’ from Ajanta Pharma |
|
2012 |
Dabur achieved USD billions turnover |
|
2013 |
Dabur’s market capitalization crosses $5 billion |
|
2015 |
Dabur’s brand namely REAL, Vatika and Amla crosses Rs. 1000 crore turnover |
|
2016 |
Dabur’s brand namely Dabur Gulabari and Dabur Lal Dant Manjan reached Rs.100 crore turnover |
|
2017 |
Dabur acquires a South African Company |
|
2019 |
Dabur appoints new Global CEO , Mr. Mohit Malhotra |
|
2020 |
Dabur rolls out 60 new Dabur products |
|
2021 |
Dabur’s market capitalization crosses Rs. 1 lakh crore |
|
2022 |
Dabur’s Red Paste Turn over crosses Rs.1000 crore. Dabur revenue crosses Rs.10000 crore |
|
2023 |
Dabur acquired majority stakes in Badshah Masala |
|
2024 |
Acquired Sesa Care to reinforce its leadership in the Rs 900 crore ayurvedic hair oil segment |
|
2025 |
Adopted a growth strategy through mergers and acquisitions, premiumization of products, and diversification into new-age healthcare and wellness segments . |
Dabur India Limited Company Information
|
Company Information |
|
|
Trade Name |
Dabur India Limited |
|
Founded year |
1884 |
|
Founder |
S.K. Burman |
|
Headquarters |
Ghaziabad, Uttar Pradesh, India |
|
Industry |
Consumer goods |
|
Chairman |
Mr. Mohit Burman |
|
Revenue |
Rs. 126.19 billion approximately |
|
Net Income |
Rs.17.81 billion approximately |
|
NSE code |
NSE: DABUR |
|
BSE code |
BSE: 500096 |
Inside Dabur India Limited
Financial Highlights
For FY 2025-26, Dabur India registered a consolidated net profit of Rs 508 crore in the first quarter of 3% year-over-year growth, while revenues improved to about Rs 3,405 crore. The firm recorded its best quarterly sales ever in June 2025 at Rs 3,404.58 crore, highlighting improved operational efficiency and robust dividend payments. Though there were some cost hikes, the firm's profitability margin remained healthy backed by effective control over expenses.
Strategic Corporate Initiatives
Dabur's 50th Annual General Meeting in August 2025 set its direction to drive rural reach, introduce new premium offers, and improve sustainability initiatives, including a pledge for renewable energy that accounted for more than 60% of its usage. The company also extended its distribution network to more than 8.4 million outlets, reinforcing long-term growth targets.
Investor Communications
During 2025, Dabur interacted proactively with investors at key platforms like the Nuvama India Conference and J.P. Morgan India Investor Summit, highlighting its strategic turns towards innovation, market expansion, and new age wellness products.
Regulatory Matters
In September 2025, Dabur was served a heavy tax notice of Rs 271.6 crore together with an equal penalty by Chandigarh tax authorities, which the company is challenging while confirming no disruption to its current operations.
Market and Product Developments
Dabur continued its product innovation drive in the ayurvedic and wellness segments, launching a number of new products throughout the year to fuel growth and capture evolving consumer choices.
Share Price Trends
In spite of certain industry-wide oscillations, Dabur stock price remained relatively stable around Rs 515 during September 2025 due to its robust business model and steady financial performance.
Dabur Share Price
|
Company Name |
Sector |
Share Price Link |
|
Dabur India Limited |
FMCG |
Milestones of Dabur India Limited
|
Year |
Milestones |
|
1884 |
Dr. S.K. Burman established Dabur at Kolkata, India |
|
1896 |
Set up a Dabur mass production manufacturing plant |
|
Early 1900s |
Dabur entered into Ayurvedic medicines |
|
1920 |
Dabur established two more manufacturing units at Narendrapur and Daburgram. Dabur expanded to Bihar and North East. |
|
1936 |
Dabur established as company ‘ Dabur India (Dr.S.K. Burman) Private Limited’ |
|
1972 |
Dabur shifted its business to Delhi with a new manufacturing unit at Faridabad. |
|
1986 |
Dabur converted into Dabur India Limited |
|
1992 |
Dabur in joint venture with Agrolimen, Spain for manufacture of confectioneries. |
|
1994 |
Dabur raised funds through IPO where the Dabur share price was oversubscribed by 21 times. |
|
1996 |
Dabur created three separate divisions such as Health, Family and Ayurvedic |
|
1997 |
Dabur launched Project STARS and processed food division |
|
1998 |
Dabur included a non-family member as CEO first time |
|
2000 |
Dabur turnover crosses Rs. 1000 crores. |
|
2005 |
Dabur acquired an entity named Balsara which deals in oral care business . Dabur announced Bonus issue of Dabur share price to bonus at ratio of 1:1 |
|
2006 |
Dabur’s market capitalization crosses $2 billion. Dabur adopted to Unted States GAAP . Dabur raised funds from international market through bonds, FCCBs, GDR, ADR , QIPs etc.. for value of $200 million |
|
2007 |
Dabur merged its own subsidiary “Dabur Foods Limited’ |
|
2009 |
Dabur Red Paste crosses billion-rupee turnover. |
|
2010 |
Dabur acquired Hobi Kozmetik Group, Turkey for $69 million and Namaste Laboratories LLC , United States for $100 million |
|
2012 |
Dabur achieved turnover in USD billions |
|
2013 |
Dabur’s market capitalization crosses $5 billion |
|
2015 |
Dabur’s brand namely REAL, Vatika and Amla crosses Rs. 1000 crore turnover |
|
2016 |
Dabur’s brand namely Dabur Gulabari and Dabur Lal Dant Manjan reached Rs.100 crore turnover |
|
2019 |
Dabur appoints new Global CEO , Mr. Mohit Malhotra |
|
2021 |
Dabur’s market capitalization crosses Rs. 1 lakh crore |
|
2022 |
Dabur’s Red Paste Turn over crosses Rs.1000 crore. Dabur revenue crosses Rs.10000 crore |
|
2023 |
Dabur acquired majority stakes in Badshah Masala |
|
2024 |
Broadened its Ayurvedic range with 14 new products and has made a major milestone by signing an MoU to build its first manufacturing plant in South India. |
|
2025 |
Launched a 100% Pure Aloe Vera Gel with the added power of hyaluronic acid and celebrated its 50th Annual General Meeting |
Conclusion
Dabur India Limited, established in 1884, has evolved into a global leader in Ayurveda and natural healthcare, with a strong presence in over 120 countries. Over its 139-year history, Dabur has consistently combined ancient Ayurvedic practices with modern science to deliver innovative healthcare, personal care, and food products. The company’s market capitalization surpassed Rs. 1 lakh crore in 2021, further solidifying its dominance in the FMCG sector. Looking forward, Dabur remains focused on growth and sustainability, maintaining its legacy as a trusted brand.
Empower your financial future with Enrich Money—your gateway to smart investing. Explore opportunities in stocks like Dabur India Limited and beyond with our user-friendly platform. Join millions who have already taken control of their financial path with us. With Enrich Money, you're not just trading stocks—you're shaping your financial success.
Frequently Asked Questions
What is Dabur Share price Today?
Dabur share price today is available on Enrich Money's stock analysis page.
Where can I view the Dabur Share Price?
You can view the Dabur Share Price at Enrich Money.
Where can I find detailed analysis of Dabur share price ?
At Enrich Money’s stock analysis page, traders can find the Dabur Share Price and its stock analysis.
Where to find Current Dabur Share Price?
You can find the current Dabur share price at Enrich Money.
What will be the target for Dabur Share Price in 2025?
Dabur share price target for the year 2025 could reach Rs. 600. For real-time insights into the future of Dabur Share Price, visit Enrich Money
Check our ORCA app to analyze stocks' performance:
Dabur Industries India Ltd. Technical Analysis
Dabur Industries India Ltd. Future Price
Dabur Industries India Ltd. Financial Statements
Dabur Industries India Ltd. Shareholding Pattern
Dabur Industries India Ltd. Latest Corporate News
Dabur Industries India Ltd. Stock/Company Overview
Related Stocks
Colgate-Palmolive (India) Ltd.
Procter & Gamble Hygiene and Health Care Ltd.
Disclaimer: This blog is dedicated exclusively for educational purposes. Please note that the securities and investments mentioned here are provided for informative purposes only and should not be construed as recommendations. Kindly ensure thorough research prior to making any investment decisions. Participation in the securities market carries inherent risks, and it's important to carefully review all associated documents before committing to investments. Please be aware that the attainment of investment objectives is not guaranteed. It's important to note that the past performance of securities and instruments does not reliably predict future performance.
